Clin Exp Otorhinolaryngol.  2023 Feb;16(1):95-97. 10.21053/ceo.2022.00780.

The Effects of Statin Medications on Postoperative Outcomes in Patients With Chronic Rhinosinusitis

• Min HK
• Lee HJ
• Doo JG
• Kim SW
• Min JY

• KMID: 2539773
• DOI: http://doi.org/10.21053/ceo.2022.00780

Reference

1. Ascer E, Bertolami MC, Venturinelli ML, Buccheri V, Souza J, Nicolau JC, et al. Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients. Atherosclerosis. 2004; Nov. 177(1):161–6.

2. Case CC, Ballantyne CM. Statins and inflammatory markers. Curr Atheroscler Rep. 2002; Jan. 4(1):42–7.

3. Wang W, Le W, Ahuja R, Cho DY, Hwang PH, Upadhyay D. Inhibition of inflammatory mediators: role of statins in airway inflammation. Otolaryngol Head Neck Surg. 2011; Jun. 144(6):982–7.

4. Wilson JH, Payne SC, Fermin CR, Churnin I, Qazi J, Mattos JL. Statin use protective for chronic rhinosinusitis in a nationally representative sample of the United States. Laryngoscope. 2020; Apr. 130(4):848–51.

5. Gilani S, Bhattacharyya N. The potential protective effects of statins in chronic rhinosinusitis: a case-control study. Laryngoscope. 2021; May. 131(5):E1431–3.

6. Kim JH, Wee JH, Choi HG, Park JY, Hwang YI, Jang SH, et al. Association between statin medication and asthma/asthma exacerbation in a national health screening cohort. J Allergy Clin Immunol Pract. 2021; Jul. 9(7):2783–91.

7. Fokkens WJ, Lund VJ, Hopkins C, Hellings PW, Kern R, Reitsma S, et al. European Position Paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020; Feb. 58(Suppl S29):1–464.

8. Kim DY, Ryu SY, Lim JE, Lee YS, Ro JY. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model. Eur J Pharmacol. 2007; Feb. 557(1):76–86.

9. Huang CF, Peng HJ, Wu CC, Lo WT, Shih YL, Wu TC. Effect of oral administration with pravastatin and atorvastatin on airway hyperresponsiveness and allergic reactions in asthmatic mice. Ann Allergy Asthma Immunol. 2013; Jan. 110(1):11–7.

10. Liou CJ, Cheng PY, Huang WC, Chan CC, Chen MC, Kuo ML, et al. Oral lovastatin attenuates airway inflammation and mucus secretion in ovalbumin-induced murine model of asthma. Allergy Asthma Immunol Res. 2014; Nov. 6(6):548–57.